[LXRX] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
25-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- 4.51%
YoY- -57.10%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 702 28 14 199 8,727 17,071 33,047 -47.35%
PBT -48,244 -30,494 -25,611 -5,495 -51,138 -16,781 -32,387 6.86%
Tax -2,977 216 -14 -174 335 -102 -4,009 -4.83%
NP -48,244 -30,710 -25,611 -5,495 -51,138 -16,781 -28,378 9.24%
Tax Rate - - - - - - - -
Total Cost 48,946 30,738 25,625 5,694 59,865 33,852 61,425 -3.71%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -6,872.36 -109,678.57 -182,935.71 -2,761.31 -585.97 -98.30 -85.87 107.52%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.20 -0.16 -0.17 -0.04 -0.48 -0.16 -0.27 -4.87%
EPS Diluted -0.20 -0.16 -0.17 -0.04 -0.48 -0.16 -0.27 -4.87%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.